EMEA-000914-PIP01-10-M05 - paediatric investigation plan
eftrenonacog alfa
PIPHuman
Swedish Orphan Biovitrum AB (publ)
E-mail: medical.info@sobi.com
Tel. +46 8697 2000
P/0071/2020: EMA decision of 18 March 2020 on the acceptance of a modification of an agreed paediatric investigation plan for Eftrenonacog alfa (Alprolix) (EMEA-000914-PIP01-10-M05)